Evidence map›Paper›PMID 18216113›Full record

ArticleJournal of virology2008

Short-lived infected cells support virus replication in sooty mangabeys naturally infected with simian immunodeficiency virus: implications for AIDS pathogenesis.

Shari N Gordon, Richard M Dunham, Jessica C Engram, Jacob Estes, Zichun Wang, Nichole R Klatt, Mirko Paiardini, Ivona V Pandrea, Cristian Apetrei, Donald L Sodora and 8 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 1 country.

Shari N GordonUniversity of Pennsylvania School of Medicine, 705 Stellar-Chance Laboratories, 422 Curie Boulevard, Philadelphia, PA 19143, USA.
Richard M Dunham
Jessica C Engram
Jacob Estes
Zichun Wang
Nichole R Klatt
Mirko Paiardini
Ivona V Pandrea
Cristian Apetrei
Donald L Sodora
Ha Youn Lee
Ashley T Haase
Michael D Miller
Amitinder Kaur
Silvija I Staprans
Alan S Perelson
Mark B Feinberg
Guido Silvestri
Emory National Primate Research CenterUniversity of Pennsylvania · USTulane University · USUniversity of Minnesota · USCenter for Infectious Disease Research · USGilead Sciences (United States) · USHarvard University · USLos Alamos National Laboratory · USNew England Biolabs (United States) · USUnited States Military Academy · USUniversity of Rochester · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
MODELING VIRAL AND T LYMPHOCYTE DYNAMICSR01RR006555 · NCRR · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 1991 to 2011
$3.9M
Immune System Modeling/HIVR01AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 1990 to 2021
$3.7M
Host specific responses in SIV-induced hematosuppressionR01HL075766 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SILVESTRI, GUIDO · 2003 to 2007
$3.5M
Pathogenesis of SIV in African green monkeysR01AI064066 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2005 to 2010
$2.8M
Pathogenesis of New SIVsm Lineages in Rhesus MacaquesR01AI065325 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2006 to 2009
$2.6M
Immune System Modeling/HIVR37AI028433 · NIAID · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI PERELSON, ALAN S · 2002 to 2011
$2.4M
Studies of the HIV-associated cell cycle diseaseR01AI052755 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SILVESTRI, GUIDO · 2003 to 2006
$1.6M
Cell immune responses in SIV-infected sooty mangabeysR01AI049809 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KAUR, AMITINDER · 2001 to 2004
$1.1M
Viral Cytopathicity in CD4-Low SIV Passaged MangabeysR21AI060451 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI PETERSON, DOLORES MURL · 2005 to 2006
$530k
NCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400NCRR NIH HHS P51 RR000165NCRR NIH HHS R01 RR006555NCRR NIH HHS RR-00165NCRR NIH HHS RR06555NHLBI NIH HHS HL75766NHLBI NIH HHS R01 HL075766NIAID NIH HHS AI28433NIAID NIH HHS AI52755NIAID NIH HHS AI60451NIAID NIH HHS AI64066NIAID NIH HHS AI65325NIAID NIH HHS AI66996NIAID NIH HHS R01 AI028433NIAID NIH HHS R01 AI049809NIAID NIH HHS R01 AI052755NIAID NIH HHS R01 AI064066NIAID NIH HHS R01 AI065325NIAID NIH HHS R01-AI49809NIAID NIH HHS R21 AI060451NIAID NIH HHS R37 AI028433PHS HHS 1F31A1066400-01A1
6 · The paper itself

Abstract

Sooty mangabeys (SMs) naturally infected with simian immunodeficiency virus (SIV) do not develop AIDS despite high levels of virus replication. At present, the mechanisms underlying this disease resistance are poorly understood. Here we tested the hypothesis that SIV-infected SMs avoid immunodeficiency as a result of virus replication occurring in infected cells that live significantly longer than human immunodeficiency virus (HIV)-infected human cells. To this end, we treated six SIV-infected SMs with potent antiretroviral therapy (ART) and longitudinally measured the decline in plasma viremia. We applied the same mathematical models used in HIV-infected individuals and observed that SMs naturally infected with SIV also present a two-phase decay of viremia following ART, with the bulk (92 to 99%) of virus replication sustained by short-lived cells (average life span, 1.06 days), and only 1 to 8% occurring in longer-lived cells. In addition, we observed that ART had a limited impact on CD4(+) T cells and the prevailing level of T-cell activation and proliferation in SIV-infected SMs. Collectively, these results suggest that in SIV-infected SMs, similar to HIV type 1-infected humans, short-lived activated CD4(+) T cells, rather than macrophages, are the main source of virus production. These findings indicate that a short in vivo life span of infected cells is a common feature of both pathogenic and nonpathogenic primate lentivirus infections and support a model for AIDS pathogenesis whereby the direct killing of infected cells by HIV is not the main determinant of disease progression.

Indexed as

AnimalsAnti-HIV AgentsCD4 Lymphocyte CountCercocebus atysModels, TheoreticalSimian Immunodeficiency VirusViral LoadViremiaAnti-HIV Agents

Identifiers

PMID18216113
PMCPMC2268472
OpenAlexW2098129749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.